Propylparaben

Propylparaben

SCHEMBL1903370

CCCOC(=O)c1ccc(O)cc1.Oc1ccccc1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.86
ESR1 P03372 4/20 0.86
TSHR P16473 2/20 0.86
TDP1 Q9NUW8 2/20 0.86
CHRM1 P11229 1/20 0.86
SLC6A2 P23975 1/20 0.86
KDR P35968 1/20 0.86
LMNA P02545 3/20 0.77
SMN1; SMN2 Q16637 2/20 0.70
CYP1A2 P05177 1/20 0.70
CYP2D6 P10635 1/20 0.70
MAPK1 P28482 1/20 0.70
CYP2C19 P33261 1/20 0.70
NR1H2 P55055 1/20 0.70
RNASEL Q05823 1/20 0.70
ESR2 Q92731 2/20 0.66
CA12 O43570 1/20 0.62
CA1 P00915 1/20 0.62
CA2 P00918 1/20 0.62
CA7 P43166 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenol SCHEMBL28097309 0.95 LMNA (0.86) ALDH1A1ESR1TSHRTDP1CHRM1
Propylparaben SCHEMBL429594 0.93 ESR1 (1.00) ALDH1A1ESR1TSHRTDP1CHRM1
Propylparaben SCHEMBL977 0.93 ESR1 (1.00) ALDH1A1ESR1TSHRTDP1CHRM1
Propylparaben SCHEMBL11484158 0.92 ALDH1A1 (0.78) ALDH1A1ESR1TSHRTDP1CHRM1
Propylparaben SCHEMBL8427362 0.92 ALDH1A1 (0.78) ALDH1A1ESR1TSHRTDP1CHRM1
Propylparaben SCHEMBL28219717 0.92 ESR1 (0.78) ALDH1A1ESR1TSHRTDP1CHRM1
Propylparaben SCHEMBL7668086 0.92 ALDH1A1 (0.83) ALDH1A1ESR1TSHRTDP1CHRM1
Propylparaben SCHEMBL6129826 0.91 ALDH1A1 (0.89) ALDH1A1ESR1TSHRTDP1CHRM1
Propylparaben SCHEMBL6315856 0.91 ESR1 (0.96) ALDH1A1ESR1TSHRTDP1CHRM1
Propylparaben SCHEMBL1135822 0.91 ESR1 (0.96) ALDH1A1ESR1TSHRTDP1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178489-B2 Liquid, in a buffer which has a pH of 4.8 to 6.7; Aviptadil (VIP, vasoactive intestinal peptide); storage stability; use treating hypertension, cancer, respiratory system disorders, genetic disorders, neurodegenerative diseases MONDOBIOTECH AG (CH) 2012-05-15 US claimed
EP-1855661-B1 FORMULATION FOR AVIPTADIL MONDOBIOTECH AG (CH) 2011-05-04 EP claimed
US-20080161237-A1 Formulation For a Viptadil RELIEF THERAPEUTICS INTERNATIONAL SA (CH) 2008-07-03 US claimed
EP-1855661-A1 FORMULATION FOR AVIPTADIL MondoBIOTECH Licensing Out AG (CH) 2007-11-21 EP claimed
WO-2006094764-A1 FORMULATION FOR AVIPTADIL MONDOBIOTECH LICENSING OUT AG (CH) 2006-09-14 WO claimed
CN-103517909-A Novel anti-platelet compound addition salt GUANGZHOU HEERSHI PHARMA DEV CO LTD 2014-01-15 CN disclosed